Prostate Cancer International is conducting a series of free webinars for patients and caregivers in October, November, and December. Next Wednesday, October 11th, at 2:00 p.m. Eastern Time, Jan Manarite will lead a webinar for newly diagnosed prostate cancer patients. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, new, webinar | Leave a comment »
So the other morning your sitemaster learned that a relatively new FirstWord Therapy Report had come out that dealt with future use of biopharmaceuticals in the treatment of progressive and advanced prostate cancer. … READ MORE …
Filed under: Drugs in development | Tagged: analysis, development, drug, information, new, ongoing | 4 Comments »
A new article with the above title (by Andrew Zaleski) on the CNBC web site gives background on some of the wide range of new tests that are starting to help to tell us who really needs early treatment for prostate cancer and who doesn’t. This article may be a useful backgrounder of many readers … but it doesn’t address all of these new tests …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, new, prognosis, tests | 2 Comments »
For the past 15 or so years, the daVinci brand of surgical robot, developed and made by Intuitive, has dominated the marketplace for surgical robots. However, changes are coming that may challenge that effective monopoly. … READ MORE …
Filed under: Management, Treatment | Tagged: innovation, new, robot, robot-assisted, surgery | Leave a comment »
For readers who are interested in the processes and the speed with which potential new cancer drugs can be brought to market here in the USA (and other places around the world too), there in an important article in this week’s New England Journal of Medicine. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: development, drug, effectiveness, new, safety, speed | Leave a comment »
Another new article (to be published in European Urology) has used data from > 25,000 patients to validate the proposed IUSP grading system, scheduled to replace the Gleason grading system over the next few years. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: grading, ISUP, new, system, validation | 10 Comments »
On Tuesday this week, Dr. James L. Mohler of Roswell Park Cancer Institute participated in an hour-long discussion on key issues related to the diagnosis and management of early stage prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, Management, new, tests | 2 Comments »
According to this story on the Bloomberg.com web site, a West Coast billionaire called Carl Berg “is investing hundreds of millions of dollars” to develop a better test for prostate cancer and bring it to market. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: new, risk, test | Leave a comment »
As some of our regular readers will be aware, a new form of cancer therapy known as “chimeric antigen receptor T-cell” therapy (often known as CART or CAR-T) is currently in advanced stages of development. … READ MORE …
Filed under: Drugs in development | Tagged: CAR-T, cost, drug, economics, new, Treatment | 2 Comments »
For most of the past 20 years it has generally been considered that it took 10 years to show that a new form of therapy was effective and safe in the treatment of localized prostate cancer. We may need to seriously re-assess that time period. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: life, new, outcome, quality, survival, Treatment | 4 Comments »
So today’s early morning session of the GU Oncology meeting was highly focused on the evolution of newer therapies affecting the androgen receptor pathways in the treatment of advanced and progressive forms of prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, androgen, enzalutamide, new, pathway, therapies | Leave a comment »
With the publication of data about enzalutamide in the New England Journal of Medicine last week, Professor Alan Ashworth, the head of the Institute for Cancer Research (ICR) in the UK, proclaimed “a golden age in prostate cancer drug discovery.” … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: drug, golden, new, survival, therapy | 6 Comments »
The January 2012 issue of Oncology contains an open access, full-text article on the future sequencing of the recently approved and potentially new drugs that are or should soon be available for the treatment of advanced prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: advanced, drugs, new, sequencing | 1 Comment »
The “New” Prostate Cancer InfoLink is pleased to see that — here in the USA — the National Comprehensive Cancer Network (NCCN) has just issued a fully revised, new edition of the NCCN Guidelines for Patients™ for Prostate Cancer (Version 1.2011). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: edition, guideline, NCCN, new, patient | 5 Comments »
As of 10:00 am this morning Eastern Standard Time, the American Cancer Society issued the following media release about newly published guidelines on screening for prostate cancer. We have given this press release in full, without further comment at this time. The only addition to the press release is the direct link to the complete, newly-published guidelines. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: American Cancer Society, guidelines, new, screening | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 